SCHEMBL30495202

SCHEMBL30495202

CCc1nc2c(Br)cc(C)cc2c(=O)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 4/20 0.46
▸ PARP4 Q9UKK3 4/20 0.46
▸ TNKS2 Q9H2K2 1/20 0.45
▸ MAPK1 P28482 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ PPARG P37231 3/20 0.44
▸ NCOR2 Q9Y618 3/20 0.44
▸ CCR6 P51684 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ RXFP1 Q9HBX9 2/20 0.43
▸ MAPT P10636 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ GLA P06280 1/20 0.42
▸ PARP2 Q9UGN5 1/20 0.41
▸ HTT P42858 2/20 0.40
▸ TP53 P04637 1/20 0.39
▸ PIM1 P11309 1/20 0.37
▸ PIM2 Q9P1W9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25361605 1.00 PARP1 (0.46) PARP1PARP4TNKS2MAPK1MEN1
SCHEMBL22101199 0.83 PARP1 (0.47) PARP1PARP4TNKS2L3MBTL1ALDH1A1
SCHEMBL22101275 0.79 PARP4 (0.63) PARP1PARP4TNKS2MAPK1MEN1
SCHEMBL30494981 0.78 PARP1 (0.49) PARP1PARP4TNKS2MAPK1MEN1
SCHEMBL25359756 0.78 PARP1 (0.49) PARP1PARP4TNKS2MAPK1MEN1
SCHEMBL22101365 0.76 PARP1 (0.47) PARP1PARP4TNKS2MAPK1MEN1
SCHEMBL25363387 0.72 TNKS (0.58) PARP1TNKS2MAPTALDH1A1PARP2
SCHEMBL17298077 0.72 TNKS2 (0.64) PARP1TNKS2MEN1KMT2ATDP1
SCHEMBL22101318 0.71 PARP4 (0.44) PARP1PARP4TNKS2MAPK1MEN1
SCHEMBL3927954 0.71 PARP1 (0.70) PARP1ALDH1A1PIM1PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023159155-A1 INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) AND USES THEREOF PIVALENT THERAPEUTICS, INC. (US) 2023-08-24 — — WO disclosed
Send feedback